At the SCICONX Journal of Advances in Diabetes Biology (JADB), the peer review process is designed to ensure scientific rigor, transparency, fairness, and integrity. Our review model prioritizes methodological soundness, biological insight, and constructive scholarly dialogue.

We are committed to delivering high-quality editorial decisions while maintaining reasonable turnaround times and a respectful author experience.

1. Overview of the Review Model

JADB follows a double-blind peer review system, in which:

• Reviewer identities remain confidential to authors
• Author identities remain confidential to reviewers

This approach minimizes bias and supports objective evaluation based solely on scientific merit.

Each manuscript undergoes a structured, multi-stage evaluation process before a final decision is reached.

2. Stage 1: Initial Editorial Assessment (Pre-Review Screening)

Upon submission, every manuscript is evaluated by the Editor-in-Chief or a designated Handling Editor to determine:

• Alignment with the journal’s scope in diabetes biology
• Originality and scientific relevance
• Ethical compliance (human/animal research approvals)
• Completeness of submission materials
• Adherence to formatting guidelines

At this stage, manuscripts may receive:

• Desk Rejection (if outside scope or lacking sufficient scientific rigor)
• Forwarding for External Peer Review

This initial screening ensures that only manuscripts meeting baseline quality standards proceed to expert evaluation.

3. Stage 2: Reviewer Selection

For manuscripts that pass initial screening:

• A minimum of two independent expert reviewers are invited
• Reviewers are selected based on subject-matter expertise in relevant areas of diabetes biology
• Conflicts of interest are carefully assessed
• Geographic and institutional diversity are considered when possible

Reviewers are provided with structured guidance to ensure comprehensive and balanced assessments.

4. Stage 3: External Peer Review

Reviewers are asked to evaluate manuscripts across the following dimensions:

Scientific Validity

• Are hypotheses clearly defined?
• Is the study design appropriate and reproducible?
• Are statistical analyses correctly applied?

Biological Insight

• Does the study contribute new mechanistic understanding?
• Are molecular or cellular interpretations justified?
• Does the work advance current knowledge?

Data Integrity

• Are data clearly presented and accurately interpreted?
• Are figures and tables transparent and well-labeled?
• Is sufficient methodological detail provided?

Clarity & Organization

• Is the manuscript logically structured?
• Are conclusions supported by evidence?
• Is the discussion balanced and critical?

Reviewers provide detailed comments for authors and confidential recommendations for editors.

5. Editorial Decision Making

After receiving reviewer reports, the Handling Editor:

• Evaluates the depth and consistency of reviews
• Assesses reviewer recommendations
• Synthesizes key scientific concerns
• Makes an evidence-based decision

Possible decisions include:

• Accept
• Minor Revisions
• Major Revisions
• Reject

In cases of conflicting reviews, additional reviewers may be consulted. Editorial decisions are accompanied by structured feedback to guide authors in strengthening their work.

6. Revision Process

When revisions are requested:

• Authors must submit a detailed point-by-point response addressing all reviewer comments
• Revised manuscripts are evaluated by the Handling Editor
• In major revision cases, manuscripts may be returned to original reviewers for re-evaluation

The revision process is intended to improve clarity, strengthen methodology, and refine interpretation - not merely to meet formal requirements.

7. Final Acceptance & Production

Once a manuscript meets scientific and editorial standards:

• Final acceptance is issued
• The manuscript enters copyediting and formatting
• Authors review proofs prior to publication
• The article is published online as open access

All accepted articles receive permanent digital archiving and DOI assignment.

8. Ethical Oversight During Peer Review

JADB maintains strict oversight to ensure ethical compliance throughout the review process:

• Plagiarism screening using similarity detection tools
• Investigation of suspected data fabrication or image manipulation
• Review of ethical approval documentation
• Enforcement of conflict-of-interest disclosures

If ethical concerns arise at any stage, the editorial team follows structured investigative procedures in accordance with international publishing standards.

9. Transparency and Fairness

JADB is committed to:

• Objective and unbiased editorial decisions
• Respectful communication with authors and reviewers
• Protection of confidential information
• Timely processing of submissions

Authors are informed promptly of decisions and provided with detailed feedback, even in cases of rejection.

10. Appeals and Complaints

Authors who believe a decision was based on misunderstanding or procedural oversight may submit a formal appeal. Appeals must:

• Clearly outline the grounds for reconsideration
• Provide scientific justification
• Avoid repetition of previously addressed arguments

Appeals are reviewed by senior editorial leadership, and decisions following appeal are considered final.

11. Commitment to Continuous Improvement

JADB regularly evaluates its peer review system to ensure:

• High scientific standards
• Reviewer accountability
• Editorial transparency
• Fair treatment of contributors

We value reviewer dedication and author trust as central pillars of our scholarly community.

Our Peer Review Philosophy

The goal of peer review at JADB is not simply to filter submissions - it is to elevate scientific quality. Through collaborative critique, rigorous evaluation, and transparent editorial oversight, we aim to advance knowledge in diabetes biology and contribute meaningfully to global research efforts.